Related Experiment Video
Updated: Aug 18, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Hypertension in chronic renal failure and ESRD: prevalence, pathophysiology, and outcomes
1New York University School of Medicine, NY, USA. lihbpneph@aol.com
Insights
Cardiovascular diseases are the leading cause of death in patients with kidney disease, despite advances in treatment. Understanding the complex interplay of hypertension and other risk factors is crucial for developing effective therapies.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular disease (CVD) is the primary cause of mortality in patients with end-stage renal disease (ESRD).
- Despite technological and pharmacological advancements over 40 years, CVD remains the leading cause of death across all stages of renal disease, including chronic renal insufficiency, ESRD on dialysis, and renal transplant recipients.
- The high prevalence of CVD in renal patients is linked to numerous cardiovascular risk factors, including hypertension, cardiac fibrosis, hypertrophy, dyslipidemia, smoking, and sympathetic overactivity.
Purpose of the Study:
- To highlight the persistent and increasing burden of cardiovascular diseases in patients with chronic kidney disease.
- To emphasize the critical need for a comprehensive understanding of the pathophysiology and prevalence of hypertension and its associated cardiovascular risks in renal patients.
- To underscore the importance of this understanding for the development of more effective therapies and clinical trials.
Main Methods:
- Analysis of national data, specifically from the US Renal Data System (USRDS).
- Review of existing literature on cardiovascular risk factors and their prevalence in renal patient populations.
- Examination of the interaction between hypertension and other cardiovascular risks in the context of chronic kidney disease.
Main Results:
- Left ventricular hypertrophy and abnormal echocardiograms are observed in 75%–80% of incident dialysis patients.
- The prevalence of underlying cardiac disease is increasing in patients with chronic renal failure.
- Nephrologists are currently managing an epidemic of cardiovascular diseases within their patient population.
Conclusions:
- Cardiovascular diseases represent a major and growing health crisis in patients with renal impairment.
- A deeper understanding of hypertension and associated risk factors in renal disease is essential for improving patient outcomes.
- Targeted therapies and well-designed clinical trials are needed to address the high cardiovascular mortality in this vulnerable population.
Abstract:
Hypertension and cardiovascular disease were detected to be major problems in end-stage renal disease patients soon after the application of chronic dialysis to treat uremia. Nearly 40 years later, and despite awesome technological and pharmacological advances, cardiovascular diseases remain the number one cause of death in all categories of renal patients, ie, chronic renal insufficiency, end-stage renal disease on dialysis and the renal transplant recipient. This is quite likely related to the massive clinical burden of cardiovascular risk factors: hypertension, cardiac fibrosis and hypertrophy, abnormal lipid profiles, smoking, dietary factors, and enhanced sympathetic activity. For example, left ventricular hypertrophy and abnormal echocardiograms are present in up to 75% to 80% of incident dialysis patients related to the interactions of these cardiovascular risks. It is important to understand how hypertension and the other cardiovascular disease risk factors interact in these patients. Based on the latest national data from the USRDS, the prevalence of underlying cardiac disease is increasing during the period of chronic renal failure. A proper understanding of the pathophysiology and prevalence of hypertension and its consequences in renal patients may lead to more rational therapies and clinical trials. At this time, the nephrologists are dealing with an epidemic of cardiovascular diseases in their patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Diabetic Nephropathy

